drugset
drugset / Trial / NCT00938392

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly

NCT00938392 ↗

Phase 3 Completed 726 enrolled GlaxoSmithKline
RandomizedParallel-groupTriple-blindPrevention

Summary

The objective of the study is to evaluate immunogenicity between different formulations of GSK Biologicals' investigational vaccine GSK2186877A.

Timeline

Start
2009-07-30
Primary completion
2009-10-05
Completion
2009-10-05

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK2186877A Vaccine — Intramuscular

Indications

influenza